Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01368848
Recruitment Status : Completed
First Posted : June 8, 2011
Last Update Posted : August 30, 2013
Roche Pharma AG
Information provided by (Responsible Party):
Arbeitsgemeinschaft medikamentoese Tumortherapie

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2012
  Actual Study Completion Date : December 2012